Provectus Pharmaceuticals develops a powerful drug pipeline with minimal side effects, including a cancer drug that targets cancer tissue, as well as…
Biovista announced recently that it has entered into a research collaboration agreement with Novartis.
WaferGen Biosystems is a leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries.
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
In 2010, NCI estimated that 207,090 women were diagnosed with breast cancer, while 39,840 women likely died from the disease.
Switzerland is a special place. There is a lot of money from around the world here, including Russia and the Middle East, that is looking for investments.
Insituvue is preparing to commercialize the Sonic Flashlight technology, a device developed at University of Pittsburgh that gives medical professionals a better view during procedures.
Parting is such sweet sorrow when building a company from infancy and then letting go to see it spread its wings. Planning a proper exit strategy is crucial and not just when referring to love and war.
OR Pharma previously presented at OneMedForum San Francisco and will return in June to preset their technology at OneMedForum NY 2011.
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
Copyright © 2025 | WordPress Theme by MH Themes